Clinical Study | Office of Clinical Research

A Study Of Ly3303560 In Participants With Early Symptomatic Alzheimer's Disease

Posted Date: Aug 27, 2019

Investigator: Lawrence Goldstick
Specialties:
Type of Study: Drug

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease.

Criteria:

Null

Keywords:

Alzheimer's Disease

For More Information:

Sarah Hiti
937-535-5013
hitism@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List